POZ - Latino Hub : Treatment News : New Evidence in Debate Over Treatment as Prevention

POZ Latino / Hispanic Hub
Subscribe to:
POZ magazine
E-newsletters
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join
Username:
Password:
 

Back to home » News & Views » Treatment News


 

March 2011
February 2011
January 2011
December 2010
November 2010
October 2010
September 2010
August 2010
July 2010
June 2010
May 2010
April 2010
March 2010
February 2010
January 2010
December 2009
November 2009
October 2009
September 2009
August 2009
July 2009
June 2009
May 2009
April 2009
March 2009
February 2009
January 2009
December 2008
November 2008
October 2008
September 2008
August 2008
July 2008
June 2008
May 2008
April 2008
March 2008
February 2008
January 2008
December 2007
November 2007
October 2007
September 2007
August 2007
July 2007
June 2007
May 2007


emailrssprint

August 19, 2009

New Evidence in Debate Over Treatment as Prevention

People with viral loads less than 50 copies tend to keep their virus suppressed consistently, which lends weight to the argument that such folks are unlikely to pass their infection on to their HIV-negative sex partners, according to a study published in HIV Medicine and reported by aidsmap.

A declaration by Swiss researchers sent a shockwave through the HIV community in January 2008, when they claimed that certain heterosexual people with HIV simply couldn’t pass the virus on to their HIV-negative partners, even in the absence of condom use or other barrier methods. There were some qualifiers: Both partners needed to be sexually monogamous, and neither could have a sexually transmitted infection. Also, the HIV-positive partner needed to be adherent to his or her medication and have had an undetectable viral load for at least six months before engaging in unprotected sexual activity.

A number of studies have, in fact, demonstrated that people with HIV are far less likely to transmit the virus if they have an undetectable viral load, but the Swiss declaration was the first to claim that the risk is essentially nil. One counter-argument raised by critics: People with HIV adhering to antiretroviral (ARV) therapy may experience viral blips, where their virus goes up temporarily. This could, theoretically, increase the risk of transmission if condoms are not being used.

To examine the likelihood of blips, Christophe Combescure, PhD, from the University Hospital Geneva, in Switzerland, and his colleagues from the Swiss HIV Cohort examined data on 6,168 patients who were on ARV therapy and had successive viral load tests between 2003 and 2007. Though the frequency of visits varied, most people had viral load tested once every three months.

Combescure’s team found that when people claimed to have missed no doses of their ARVs in the previous four weeks, they had an 85 percent chance of having their HIV levels remain under 50 copies consistently. Most viral load blips were transient. In people whose virus jumped to between 200 and 1,000 copies—detectable but still associated with a very low risk of HIV transmission—66 percent went back to undetectable at the next test.

This was less true for people whose virus had jumped to more than 1,000 copies—when transmission may be more likely to occur, the authors explain. Just 30 percent of them went back to undetectable. This occurred rarely however. The overall chance that a person would go from undetectable to more than 1,000 copies was just 2 percent, and if a person was on a potent three-drug regimen this dropped to 1 percent.

In the final analysis, poor adherence or an inferior regimen explained most of the viral load increases to more than 1,000 copies. The authors concede, however, that the “data leave open the possibility that unexplained rises in viral load above 1,000 copies/ml, although rare, may occur.”

These data also do not explore the possibility that viral load in the genital compartment may be much higher than in blood, and the impact that may have on infectiousness.

NEW! Scroll down to comment on this story.

emailrssprint

 

Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The POZ team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

| Posting Rules

Previous Comments:

  comments 1 - 2 (of 2 total)    

Jon makay, nashville, 2010-09-23 17:37:34
Does anyone know of any other studies, full or partially supporting of this? I would like to know this in full about the real risk factors for a Neg top, and Poz Bottom. Any references/citations for newer studies.???

Jeton Ademaj, , 2009-08-20 13:38:29
This is good news, as any innovation in prevention is. 25 years in, there's still a powerful reflex among professionals working with PWA's to condemn any sex that isn't rubbered.

condoms are the new normal of a permanently pathologized gay sexuality...when gay men recoil from permanent condom use, some activists offer NewSpeak. Last week at GMHC 1 asked "how did we convince ourselves that barebacking is somehow NATURAL?"

i lol'd. "the human nervous system did it for us", i replied.

comments 1 - 2 (of 2 total)    


[Go to top]

Protesters hold the Hershey Company and its affiliated school accountable for condoning HIV-related discrimination. Click here to read more.
What to do if you've just been diagnosed
Qué hacer si eres recién diagnosticado

How to find a support system
Cómo encontrar un sistema de apoyo

Things you should know before starting treatment
Cosas que deberías saber antes de comenzar un tratamiento

How to handle side effects and other concerns
Cómo tratar los efectos secundarios y otros problemas de salud

How to tell someone you have HIV/AIDS
Cómo revelar tu diagnóstico de VIH/SIDA
[an error occurred while processing this directive]
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2012 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.